Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PFIZER, INC.

(PFE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Street Color: Efficacy of Pfizer/BioNTech COVID-19 Vaccine Falls to 84% From 96% After Six Months: STAT News

07/28/2021 | 12:46pm EDT


ę MT Newswires 2021
All news about PFIZER, INC.
02:34pMODERNA : U.S. administers 386.2 mln doses of COVID-19 vaccines - CDC
RE
12:30pMODERNA : Regulators could OK Pfizer boosters for older Americans this week
RE
11:07aASTELLAS PHARMA : ' and pfizer's xtandi (enzalutamide) reduced risk of death by ..
AQ
10:18aPFIZER : BioNTech Study Shows COVID-19 Vaccine Generates Strong Immune Response ..
MT
10:01aPFIZER : Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare ..
BU
09:56aMODERNA : Pfizer/BioNTech say data show COVID-19 vaccine safe and protective in ..
RE
09:32aPFIZER : Thinking about trading options or stock in Mirati Therapeutics, Pfizer,..
PR
09:15aHealth Care Stocks Trade Lower Pre-Bell Monday
MT
09:03aPFIZER : says COVID-19 vaccine works in kids ages 5 to 11
AQ
08:10aPFIZER : SVB Leerink Adjusts Pfizer PT to $50 From $49, Maintains Market Perform..
MT
More news
Analyst Recommendations on PFIZER, INC.
More recommendations
Financials (USD)
Sales 2021 80 761 M - -
Net income 2021 18 438 M - -
Net Debt 2021 28 980 M - -
P/E ratio 2021 13,0x
Yield 2021 3,59%
Capitalization 246 B 246 B -
EV / Sales 2021 3,41x
EV / Sales 2022 4,03x
Nbr of Employees 78 500
Free-Float 59,3%
Chart PFIZER, INC.
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | PFE | US7170811035 | MarketScreener
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 20
Last Close Price 43,89 $
Average target price 45,02 $
Spread / Average Target 2,58%
EPS Revisions
Managers and Directors
Albert Bourla Chairman, Chief Executive & Operating Officer
Frank A. D'Amelio Chief Financial Officer & EVP-Global Supply
Mikael Dolsten Chief Scientific Officer & Research President
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Aida Habtezion Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
PFIZER, INC.19.23%246 078
JOHNSON & JOHNSON4.68%433 701
ROCHE HOLDING AG10.97%321 442
NOVO NORDISK A/S50.80%232 556
ELI LILLY AND COMPANY36.28%208 604
ABBVIE INC.0.54%190 378